Australia · Delayed Price · Currency is AUD Pro Medicus Statistics
Total Valuation
Pro Medicus has a market cap or net worth of AUD 17.17 billion. The enterprise value is 16.92 billion.
| Market Cap | 17.17B |
| Enterprise Value | 16.92B |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Sep 7, 2026 |
Share Statistics
Pro Medicus has 104.47 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 104.47M |
| Shares Outstanding | 104.47M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 48.40% |
| Owned by Institutions (%) | 24.78% |
| Float | 53.32M |
Valuation Ratios
The trailing PE ratio is 64.80 and the forward PE ratio is 90.02. Pro Medicus's PEG ratio is 3.70.
| PE Ratio | 64.80 |
| Forward PE | 90.02 |
| PS Ratio | 65.60 |
| PB Ratio | 38.07 |
| P/TBV Ratio | 40.03 |
| P/FCF Ratio | 135.13 |
| P/OCF Ratio | 134.66 |
| PEG Ratio | 3.70 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.77, with an EV/FCF ratio of 133.17.
| EV / Earnings | 63.76 |
| EV / Sales | 64.65 |
| EV / EBITDA | 85.77 |
| EV / EBIT | 86.26 |
| EV / FCF | 133.17 |
Financial Position
The company has a current ratio of 6.85, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.85 |
| Quick Ratio | 6.75 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 74.97% and return on invested capital (ROIC) is 68.62%.
| Return on Equity (ROE) | 74.97% |
| Return on Assets (ROA) | 25.84% |
| Return on Invested Capital (ROIC) | 68.62% |
| Return on Capital Employed (ROCE) | 35.15% |
| Weighted Average Cost of Capital (WACC) | 7.44% |
| Revenue Per Employee | 1.71M |
| Profits Per Employee | 1.73M |
| Employee Count | 153 |
| Asset Turnover | 0.55 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pro Medicus has paid 112.17 million in taxes.
| Income Tax | 112.17M |
| Effective Tax Rate | 29.71% |
Stock Price Statistics
The stock price has decreased by -47.55% in the last 52 weeks. The beta is 0.58, so Pro Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -47.55% |
| 50-Day Moving Average | 175.92 |
| 200-Day Moving Average | 165.28 |
| Relative Strength Index (RSI) | 38.63 |
| Average Volume (20 Days) | 193,914 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pro Medicus had revenue of AUD 261.69 million and earned 265.34 million in profits. Earnings per share was 2.54.
| Revenue | 261.69M |
| Gross Profit | 261.29M |
| Operating Income | 196.12M |
| Pretax Income | 377.52M |
| Net Income | 265.34M |
| EBITDA | 196.49M |
| EBIT | 196.12M |
| Earnings Per Share (EPS) | 2.54 |
Balance Sheet
The company has 252.28 million in cash and 2.23 million in debt, with a net cash position of 250.05 million or 2.39 per share.
| Cash & Cash Equivalents | 252.28M |
| Total Debt | 2.23M |
| Net Cash | 250.05M |
| Net Cash Per Share | 2.39 |
| Equity (Book Value) | 450.92M |
| Book Value Per Share | 4.32 |
| Working Capital | 305.72M |
Cash Flow
In the last 12 months, operating cash flow was 127.48 million and capital expenditures -444,000, giving a free cash flow of 127.04 million.
| Operating Cash Flow | 127.48M |
| Capital Expenditures | -444,000 |
| Depreciation & Amortization | 371,000 |
| Net Borrowing | -631,000 |
| Free Cash Flow | 127.04M |
| FCF Per Share | 1.22 |
Margins
Gross margin is 99.85%, with operating and profit margins of 74.94% and 101.40%.
| Gross Margin | 99.85% |
| Operating Margin | 74.94% |
| Pretax Margin | 144.26% |
| Profit Margin | 101.40% |
| EBITDA Margin | 75.08% |
| EBIT Margin | 74.94% |
| FCF Margin | 48.55% |
Dividends & Yields
This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | 0.74 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | 25.45% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 24.41% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.46% |
| Earnings Yield | 1.55% |
| FCF Yield | 0.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Pro Medicus is 202.47, which is 23.21% higher than the current price. The consensus rating is "Buy".
| Price Target | 202.47 |
| Price Target Difference | 23.21% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 24.79% |
| EPS Growth Forecast (3Y) | 26.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pro Medicus has an Altman Z-Score of 89.44 and a Piotroski F-Score of 4.
| Altman Z-Score | 89.44 |
| Piotroski F-Score | 4 |